Uliassi, E.; Bolognesi, M. L.; Milelli, A., Targeting Tau Protein with Proximity Inducing Modulators: A New Frontier to Combat Tauopathies, «ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE», 2025, 8, pp. 654 - 672 [Scientific article]
Santini A.; Tassinari E.; Poeta E.; Loi M.; Ciani E.; Trazzi S.; Piccarducci R.; Daniele S.; Martini C.; Pagliarani B.; Tarozzi A.; Bersani M.; Spyrakis F.; Danková D.; Olsen C.A.; Soldati R.; Tumiatti V.; Montanari S.; De Simone A.; Milelli A., First in Class Dual Non-ATP-Competitive Glycogen Synthase Kinase 3β/Histone Deacetylase Inhibitors as a Potential Therapeutic to Treat Alzheimer’s Disease, «ACS CHEMICAL NEUROSCIENCE», 2024, 15, pp. 2099 - 2111 [Scientific article]
Guardigni M.; Greco G.; Poeta E.; Santini A.; Tassinari E.; Bergamini C.; Zalambani C.; De Simone A.; Andrisano V.; Uliassi E.; Monti B.; Bolognesi M.L.; Fimognari C.; Milelli A., Integrating a quinone substructure into histone deacetylase inhibitors to cope with Alzheimer's disease and cancer, «RSC MEDICINAL CHEMISTRY», 2024, 15, pp. 2045 - 2062 [Scientific article]Open Access
Milelli, A.; Catanzaro, E.; Greco, G.; Calcabrini, C.; Turrini, E.; Maffei, F.; Burattini, S.; Guardigni, M.; Sissi, C.; Schnekenburger, M.; Diederich, M.; Sestili, P.; Fimognari, C., New rhodol-sulforaphane conjugates as innovative isothiocyanate-based cytotoxic agents for cancer cells, «EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY», 2024, 280, Article number: 116936 , pp. 1 - 11 [Scientific article]
Nordio G.; Piazzola F.; Cozza G.; Rossetto M.; Cervelli M.; Minarini A.; Basagni F.; Tassinari E.; Dalla Via L.; Milelli A.; Di Paolo M.L., From Monoamine Oxidase Inhibition to Antiproliferative Activity: New Biological Perspectives for Polyamine Analogs, «MOLECULES», 2023, 28, Article number: 6329 , pp. 1 - 18 [Scientific article]Open Access
Guardigni M.; Pruccoli L.; Santini A.; Simone A.D.; Bersani M.; Spyrakis F.; Frabetti F.; Uliassi E.; Andrisano V.; Pagliarani B.; Fernández-Gómez P.; Palomo V.; Bolognesi M.L.; Tarozzi A.; Milelli A., PROTAC-Induced Glycogen Synthase Kinase 3β Degradation as a Potential Therapeutic Strategy for Alzheimer’s Disease, «ACS CHEMICAL NEUROSCIENCE», 2023, 14, pp. 1963 - 1970 [Scientific article]Open Access
Rocío Marisol Espinoza Chávez; Salerno A.; Liuzzi A.; Ilari A.; Milelli A.; Uliassi E.; Bolognesi M.L., Targeted Protein Degradation for Infectious Diseases: from Basic Biology to Drug Discovery, «ACS BIO & MED CHEM AU», 2023, 3, pp. 32 - 45 [Scientific article]Open Access
EFRAIM REYES; Liher Prieto; ANDREA MILELLI, Asymmetric Organocatalysis: A Survival Guide to Medicinal Chemists, «MOLECULES», 2022, 28, Article number: 271 , pp. 1 - 24 [Scientific article]Open Access
Ragno, Rino; Minarini, Anna; Proia, Eleonora; Lorenzo, Antonini; Milelli, Andrea; Tumiatti, Vincenzo; Fiore, Marco; Fino, Pasquale; Rutigliano, Lavinia; Fioravanti, Rossella; Tahara, Tomoaki; Pacella, Elena; Greco, Antonio; Canettieri, Gianluca; Di Paolo, Maria Luisa; Agostinelli, Enzo, Bovine Serum Amine Oxidase and Polyamine Analogues: Chemical Synthesis and Biological Evaluation Integrated with Molecular Docking and 3-D QSAR Studies, «JOURNAL OF CHEMICAL INFORMATION AND MODELING», 2022, 62, pp. 3910 - 3927 [Scientific article]Open Access
Salerno, Alessandra; Seghetti, Francesca; Caciolla, Jessica; Uliassi, Elisa; Testi, Eleonora; Guardigni, Melissa; Roberti, Marinella; Milelli, Andrea; Bolognesi, Maria Laura, Enriching Proteolysis Targeting Chimeras with a Second Modality: When Two Are Better Than One, «JOURNAL OF MEDICINAL CHEMISTRY», 2022, 65, pp. 9507 - 9530 [Scientific article]Open Access
Angela De Simone,
Vincenzo Tumiatti,
VIncenza Andrisano,
Andrea Milelli, Glycogen Synthase Kinase 3β: A New Gold Rush in Anti-Alzheimer’s Disease Multitarget Drug Discovery?, «JOURNAL OF MEDICINAL CHEMISTRY», 2021, 64, pp. 26 - 41 [Scientific article]Open Access
Loi, Manuela; Gennaccaro, Laura; Fuchs, Claudia; Trazzi, Stefania; Medici, Giorgio; Galvani, Giuseppe; Mottolese, Nicola; Tassinari, Marianna; Giorgini, Roberto Rimondini; Milelli, Andrea; Ciani, Elisabetta, Treatment with a GSK-3β/HDAC Dual Inhibitor Restores Neuronal Survival and Maturation in an In Vitro and In Vivo Model of CDKL5 Deficiency Disorder, «INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES», 2021, 22, Article number: 5950 , pp. 1 - 24 [Scientific article]Open Access
Catanzaro E.; Betari N.; Arencibia J.M.; Montanari S.; Sissi C.; De Simone A.; Vassura I.; Santini A.; Andrisano V.; Tumiatti V.; De Vivo M.; Krysko D.V.; Rocchi M.B.L.; Fimognari C.; Milelli A., Targeting topoisomerase II with trypthantrin derivatives: Discovery of 7-((2-(dimethylamino)ethyl)amino)indolo[2,1-b]quinazoline-6,12-dione as an antiproliferative agent and to treat cancer, «EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY», 2020, 202, Article number: 112504 , pp. 1 - 10 [Scientific article]Open Access
Di Paolo, Maria Luisa; Cozza, Giorgio; Milelli, Andrea; Zonta, Francesca; Sarno, Stefania; Minniti, Elirosa; Ursini, Fulvio; Rosini, Michela; Minarini, Anna, Benextramine and derivatives as novel human monoamine oxidases inhibitors: an integrated approach, «THE FEBS JOURNAL», 2019, 286, pp. 4995 - 5015 [Scientific article]
Patent n. 102019000025840, COMPOSTI ISOTIOCIANATI E ISOSELENCIANATI.
